Search

everythinglearnresearchcommunity

for

Search:↓

Topical immunotherapy with DPCP led to some hair regrowth in most pediatric alopecia areata patients, especially those with milder cases and longer treatment.

Two sisters had a rare hair condition without other usual symptoms.

Airway issues can occur in Conradi–Hünermann–Happle syndrome and can be managed with minimally invasive procedures.

Diphenylcyclopropenone (DPCP) is effective in treating alopecia areata, with most patients showing significant hair regrowth.

Hair dye ingredient PPD can cause severe allergic reactions, including facial swelling.

A specific gene variant is linked to heart disease, increased heart muscle, curly hair, and thick skin on palms and soles.

Thalidomide with CHOP is more effective for peripheral T-cell lymphoma than CHOP alone.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Diphencyprone initially increases mouse hair growth, then slows it, possibly due to changes in specific protein levels.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

TCDD reduces EGF receptor activity and causes various developmental changes in animals.

Tay syndrome is a unique genetic disorder causing skin, hair, and developmental issues.

Diphenylcyclopropenone is effective and safe for treating severe alopecia areata in children, with maintenance therapy reducing relapse risk.

PTH-CBD could help prevent and treat hair loss caused by chemotherapy in mice.

Combining DPCP with PRP doesn't improve hair regrowth in alopecia areata.

Toluene diisocyanate exposure can cause immune sensitization by interacting with proteins in hair follicles and sebaceous glands.

Two new mutations in the CDH3 gene cause hair loss and vision problems in a young girl.

Treatment improved scalp conditions and hair loss with no recurrence after 1 year.

New mutations in the EBP gene cause CDPX2, affecting bones, skin, eyes, and hair, with females generally less affected than males.

A specific gene mutation is linked to a hereditary form of dystonia that responds well to certain medications.

The thulium laser and PDRN injections effectively improved hair thickness in patients with pattern hair loss.

Ptch2 plays a key role in controlling stem cell function and the ability to regenerate after birth.

A man developed severe skin reactions after using a treatment for hair loss.

Blocking Prostaglandin D₂ (PGD₂) could help treat hair loss.

Increased ODC expression makes normally tumor-resistant mice more prone to tumor development.

Early diagnosis and treatment of TPP can prevent complications.

Awareness of Penile Thread Tourniquet Syndrome is crucial for preventing severe complications in children.

DPCP is effective for treating severe alopecia areata, but relapse is common.

The debate on direct-to-consumer pharmaceutical ads continues, with consumers finding them educational and doctors concerned about their impact on patient relationships and medication understanding.